GoodRx Holdings Past Earnings Performance
Past criteria checks 0/6
GoodRx Holdings has been growing earnings at an average annual rate of 16.4%, while the Healthcare Services industry saw earnings growing at 23.3% annually. Revenues have been growing at an average rate of 11.6% per year.
Key information
16.4%
Earnings growth rate
14.0%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | 11.6% |
| Return on equity | -2.3% |
| Net Margin | -2.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Capital Allocation Trends At GoodRx Holdings (NASDAQ:GDRX) Aren't Ideal
Dec 21
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon
Oct 29GoodRx: The Tide Is Turning The Wrong Way (Rating Downgrade)
Oct 26GoodRx Holdings: Failing To Gain Much Traction
Oct 08GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business
Sep 22GoodRx Q2 Earnings Preview
Jul 31GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt
Jul 12GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues
Jun 09Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture
Jun 06GoodRx: Encouraging Profit Stabilization (Rating Upgrade)
May 28GoodRx Holdings: Large TAM Continues To Support Growth
Mar 20GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mar 07Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?
Mar 01GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet
Feb 12GoodRx: Cost Saving Is A Strong Value Proposition To Consumers
Jan 23GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital
Jan 22GoodRx Stock Spikes After Receiving A Strong Dose Of Performance
Jan 11What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?
Dec 02GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital
Sep 12An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued
Jul 14GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business
May 27Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%
May 05Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding
May 05Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?
Mar 23GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital
Feb 07Revenue & Expenses Breakdown
How GoodRx Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 790 | -16 | 475 | 115 |
| 30 Jun 24 | 775 | -59 | 487 | 124 |
| 31 Mar 24 | 764 | -7 | 460 | 125 |
| 31 Dec 23 | 750 | -9 | 451 | 126 |
| 30 Sep 23 | 738 | 15 | 418 | 141 |
| 30 Jun 23 | 745 | 12 | 426 | 137 |
| 31 Mar 23 | 747 | -48 | 448 | 141 |
| 31 Dec 22 | 767 | -33 | 465 | 143 |
| 30 Sep 22 | 796 | -71 | 519 | 141 |
| 30 Jun 22 | 803 | -47 | 515 | 141 |
| 31 Mar 22 | 788 | -15 | 513 | 135 |
| 31 Dec 21 | 745 | -25 | 525 | 126 |
| 30 Sep 21 | 686 | -282 | 792 | 114 |
| 30 Jun 21 | 631 | -314 | 833 | 95 |
| 31 Mar 21 | 578 | -310 | 764 | 78 |
| 31 Dec 20 | 551 | -294 | 715 | 62 |
| 30 Sep 20 | 510 | 13 | 357 | 48 |
| 30 Jun 20 | 472 | 75 | 234 | 40 |
| 31 Mar 20 | 435 | 50 | 217 | 34 |
| 31 Dec 19 | 388 | 42 | 192 | 29 |
| 31 Dec 18 | 250 | 14 | 113 | 44 |
Quality Earnings: GDRX is currently unprofitable.
Growing Profit Margin: GDRX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GDRX is unprofitable, but has reduced losses over the past 5 years at a rate of 16.4% per year.
Accelerating Growth: Unable to compare GDRX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GDRX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (17.5%).
Return on Equity
High ROE: GDRX has a negative Return on Equity (-2.33%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:23 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
GoodRx Holdings, Inc. is covered by 28 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Ishan Majumdar | Baptista Research |
| Michael Cherny | BofA Global Research |